| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
|
|
||||||||
|
|
||||||||
| 日本生命グループ | ||||||||
|
|
Founded in August 2003.
In the November 11 issue of Social Insurance Monthly, Nagoya Kyozai Hospital's project to address uncollected funds, undertaken by the organization, was featured. The article introduces the hospital's practical case and emphasizes the importance of managing uncollected funds.
Media Coverage: An article about Osamu Suzuki's skin disease 'Psoriasis' was published on Toyo Keizai Online.
An article about Medical Data Vision's dementia countermeasures was published in Weekly Economist Online. The article introduces regional collaboration among medical institutions and the introduction of subcutaneous injection drugs.
An article was published in Medical Tribune stating that hospitalizations due to acute complications of diabetes have increased by 30% in the past five years. The article was released on November 8, 2026, and can be viewed on the company's news page.
Medical Data Vision Inc. announced that the number of real patients in its large-scale medical database reached 65.37 million as of the end of October 2026.
Based on MDV data, this article examines the trend in hospitalizations for "acute complications of diabetes" and the prescription practices before and after hospitalization due to severe hypoglycemia.
The news of Medical Data Vision Co., Ltd. was featured in Medical Operations. The article introduces the uncollected funds project at Nagoya Hospital and proposes measures to reduce collection efforts within the organization.
The 'Web Tool Free Trial Version' and 'Sample Search' that were temporarily suspended due to addressing vulnerabilities in external systems have resumed, as security measures and safety checks have been completed. During the suspension period, investigations found no incidents of unauthorized access or data leakage exploiting the vulnerabilities.
An article was published in Yomiuri Shimbun Online on October 23, 2026. The headline reads: 'Nippon Life Strengthens Data Strategy with MDV Acquisition… Aiming for Early Medical Consultation and New Product Development'.
In response to vulnerability information from an external system, we have temporarily suspended the 'Web Tool Free Trial Version' and 'Parameter Search'. Other functions remain available as usual, and we will notify you on this site when they resume. At this time, no attacks exploiting the vulnerability or data leaks have been confirmed.